MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 52 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,000 | -25.0% | 7,972 | -27.4% | 0.00% | – |
| Q1 2022 | $12,000 | +50.0% | 10,982 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -20.0% | 10,982 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -44.4% | 10,982 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | +12.5% | 10,982 | +46.7% | 0.00% | – |
| Q1 2021 | $16,000 | +77.8% | 7,487 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 7,487 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -25.0% | 7,487 | -25.5% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 10,051 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -20.0% | 10,051 | 0.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 10,051 | +23.6% | 0.00% | – |
| Q3 2019 | $11,000 | -8.3% | 8,134 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -20.0% | 8,134 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | 0.0% | 8,134 | 0.0% | 0.00% | – |
| Q2 2018 | $15,000 | – | 8,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 11,781,942 | $14,733,000 | 3.30% |
| ICM ASSET MANAGEMENT INC/WA | 252,900 | $357,000 | 0.28% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 504,298 | $711,000 | 0.10% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $34,848,000 | 0.09% |
| Fairpointe Capital LLC | 415,400 | $586,000 | 0.03% |
| Claraphi Advisory Network, LLC | 14,863 | $21,000 | 0.01% |
| Spark Investment Management LLC | 62,200 | $87,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,350,600 | $3,314,000 | 0.00% |
| Allworth Financial LP | 11,266 | $16,000 | 0.00% |
| A.R.T. Advisors, LLC | 11,529 | $16,000 | 0.00% |